Question

翻译一段关于医学行为治疗的片段－英文

As such, a number of opportunities exist for behavioral medicine research and practice.
First, as evidence for the link between certain types of HNC and human papillomavirus
continues to grow, research and practice must recognize the changing patient demographic,
which is becoming younger and includes considerably more females (Curado & Hashibe,
2009; Marur & Forastiere, 2008). Moreover, evidence indicates that HPV-positive HNC is
often more responsive to treatment and is associated with increased survival as compared to
HPV-negative HNC (Marur, D'Souza, Westra, & Forastiere, 2010). This implies the need to
distinguish between HNC patients with different disease etiologies (something the literature,
at present, does not address) and that current research must either be replicated in HPV-
positive HNC populations or that HNC patient populations will require stratification in the
future. In addition, because evidence suggests that (risky) sexual contact is the primary
means by which individuals with HPV-positive HNC acquire the virus (e.g., Heck et al.,
2010; Smith et al., 2004), further development of behavioral interventions targeting at-risk
persons is needed, particularly those designed to decrease risky sexual behavior, increase
knowledge regarding acquisition of the virus, and/or increase uptake of HPV vaccinations
(e.g., Cox, Cox, Sturm, & Zimet, 2010).

Answer 1

翻译：
这样，若干机会行为医学研究和实践存在。
首先，作为证据对某些类型HNC和人乳头状瘤病毒之间的联系
持续增长，研究和实践必须认识到不断变化的人口的患者，
这是越来越年轻化，其中包括相当多的女性（科拉多和Hashibe，
2009年; Marur＆Forastiere，2008）。此外，有证据表明，HPV阳性HNC是
往往更适应治疗和提高生存相比，关联
HPV阴性HNC（Marur，杜泽，Westra，与Forastiere，2010）。这意味着需要
HNC患者的不同病因病情区分（一些文献，
目前，并没有解决），而目前的研究要么必须在HPV-复制
积极HNC人群或HNC的患者人群，需要分层的
未来。另外，因为有证据表明，（风险）的性接触是主要的
装置通过其与HPV阳性HNC个体获得病毒（例如，海克。等，
2010; Smith等人，2004），行为干预的进一步发展有风险的靶向
人是需要的，特别是那些旨在减少危险性行为，增加
HPV的疫苗接种对采集的病毒的认识，和/或增加的摄取
（例如，考克斯，考克斯，斯特姆，与Zimet，2010）。